Morton Levitt - Concepedia

Author

Morton Levitt

National Heart Lung and Blood Institute

Also Known As

M E Levitt, M H Levitt, M. H. Levitt, MORTON LEVITT, Morton H. Levitt, Morton Levitt

Publications

6.4K

Citations

H-Index

Concepts

All Affiliations

National Heart Lung and Blood Institute New York State Psychiatric Institute Columbia University New York Psychoanalytic Society and Institute National Institute of Arthritis and Musculoskeletal and Skin Diseases

About

Morton Levitt is an author at National Heart Lung and Blood Institute specializing in medicine, social sciences, and pharmacology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	17	24	2K
2	Natural Sciences	3	3	298
3	Health Sciences	2	2	410
4	Engineering	1	1	58
5	Public Health	1	1	21

Morton Levitt

Publications

6.3K

Citations

H-Index

Page 1

	Year	Citations
Tyrosine Hydroxylase Toshiharu Nagatsu, Morton Levitt, Sidney Udenfriend Journal of Biological Chemistry	1964	2K
ELUCIDATION OF THE RATE-LIMITING STEP IN NOREPINEPHRINE BIOSYNTHESIS IN THE PERFUSED GUINEA-PIG HEART Morton Levitt, Sydney Spector, Albert Sjoerdsma, Journal of Pharmacology and Experimental Therapeutics	1965	1K
Biological Psychiatry Birgitta Rorsman, Olle Hagnell, Jan Lanke, Neuropsychobiology	1983	846
A rapid and simple radioassay for tyrosine hydroxylase activity Toshiharu Nagatsu, Morton Levitt, Sidney Udenfriend Analytical Biochemistry BiochemistryMedicineTyrosine Hydroxylase ActivityBioanalysisChemical Pathology	1964	506
Report of a workshop on classification of specific hepatocellular lesions in rats. Robert A. Squire, Morton Levitt PubMed HepatologySpecific Hepatocellular LesionsLiver PhysiologyHistopathologyPathology	1975	372
Compounds Affecting the Central Nervous System. 4. 3.beta.-Phenyltropane-2-carboxylic Esters and Analogs Robert B. Clarke, Sol J. Daum, A. J. GAMBINO, Journal of Medicinal Chemistry NeurotransmitterAltmetric Attention Score3.Beta.-phenyltropane-2-carboxylic EstersPharmacotherapySystem Pharmacology	1973	217
Reduction of Cardiac Tyrosine Hydroxylase Activity in Experimental Congestive Heart Failure Peter E. Pool, James W. Covell, Morton Levitt, Circulation Research Cardiac MuscleHeart FailureCardiovascular PharmacologyCardiovascular FunctionStructural Heart Disease	1967	138
Conversion of L-tyrosine to 3,4-dihydroxyphenylalanine by cell-free preparations of brain and sympathetically innervated tissues Toshiharu Nagatsu, Morton Levitt, Sidney Udenfriend Biochemical and Biophysical Research Communications NeurophysiologyPhysiologyCell-free PreparationsInnervated TissuesNeuroscience	1964	127
A new class of tyrosine hydroxylase inhibitors and a simple assay of inhibition in vivo Morton Levitt, James W. Gibb, John W. Daly, Biochemical Pharmacology Medicinal ChemistrySimple AssayTyrosine Hydroxylase InhibitorsBiochemistryMedicine	1967	123
Phenylalanine as substrate and inhibitor of tyrosine hydroxylase Masayuki Ikeda, Morton Levitt, Sidney Udenfriend Archives of Biochemistry and Biophysics Tyrosine HydroxylaseBiochemistryNatural SciencesChemical BiologyEnzymatic Modification	1967	117

Page 1